US equities |
SPCX $171.09 ▲+0.00% MU $1,063.96 ▲+0.00% NVDA $238.90 ▲+0.00% META $741.90 ▲+0.00% AMD $631.75 ▲+0.00% AMZN $251.40 ▲+0.00% INTC $116.19 ▲+0.00% SNDK $1,704.16 ▲+0.00%
FinancialContent

Latest News about Rob Conley

Recent news which mentions Rob Conley

Beckley Psytech Doses First Patients With Psilocin In Trial For Treatment Of Major Depression Disorder
Tickers NEWS
Tags major depressive disorder premium Psychedelics
From Benzinga
First Patient Dosed In Psychedelics Therapy Study For Treatment-Resistant Depression
Tickers NEWS
Tags Beckley Psytech Beckley Psytech Ltd Market News
From Benzinga